Study of ICP-105 in Solid Tumors Patients
Clinical trial NCT03642834 · COMPLETED
Trial details
- NCT number
- NCT03642834
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2020-12-14
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.